ProteoMonitor GenomeWeb News Premium Content Existing subscribers login here. New to ProteoMonitor? For a trial subscription click here.

Life Sciences a ‘Top Priority’ for Agilent
As Firm Considers M&A Options, CEO Says

[May 15, 2008]

By Tony Fong

Bill Sullivan said Agilent remains on the lookout for acquisition targets, and that the firm’s “top priority continues to be in the life-sciences area, and we will continue to look for opportunities that we believe will drive value for shareholders.”

Login | Subscribe